Hepatic changes of erythropoietin gene expression in a ratmodel of acute-phase response

Liver International

Volumn 30, Issue 1, 2010, Pages 55-64

  Ramadori, Pierluigi ^a   Sheikh, Nadeem ^a   Ahmad, Ghayyor ^a   Dudas, Jozsef ^a   Ramadori, Giuliano ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Acute phase response; Erythropoietin; HIF 1 a; HIF 2 a; Liver

Indexed keywords

ERYTHROPOIETIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; TURPENTINE OIL;

ACUTE PHASE RESPONSE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE LOCATION; HORMONE BLOOD LEVEL; KIDNEY; LIVER; MALE; NONHUMAN; ORGAN DISTRIBUTION; POLYMERASE CHAIN REACTION; RAT; REACTION TIME; RNA ANALYSIS; TARGET ORGAN; UPREGULATION;

ACUTE-PHASE PROTEINS; ACUTE-PHASE REACTION; ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; DISEASE MODELS, ANIMAL; ERYTHROPOIETIN; GENE EXPRESSION; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; KIDNEY; LIVER; RATS; RNA, MESSENGER; SOLVENTS; TURPENTINE; UP-REGULATION;

EID: 73449101463     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2009.02131.x     Document Type: Article

References (43)

1. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448-54.
2. Ceciliani F, Giordano A, Spagnolo V. The systemic reaction during inflammation: the acute-phase proteins. Protein Pept Lett 2002; 9: 211-23.
3. Gruys E, Toussaint MJ, Niewold TA, Koopmans S.J. Acute phase reaction and acute phase proteins. J Zhejiang Univ Sci B 2005; 6: 1045-56.
4. Sheikh N, Tron K, Dudas J, Ramadori G. Cytokine-induced neutrophil chemoattractant-1 is released by the non-injured liver in a rat acute-phase model. Lab Invest 2006; 86: 800-14.
5. Sheikh N, Dudas J, Ramadori G. Changes of gene expression of iron regulatory proteins during turpentine oilinduced acute-phase response in the rat. Lab Invest 2007; 87: 713-25.
6. Ramadori G, Christ B. Cytokines and the hepatic acutephase response. Semin Liver Dis 1999; 19: 141-55.
7. Roy CN, Andrews N.C. Anemia of inflammation: the hepcidin link. Curr Opin Hematol 2005; 12: 107-11.
8. Freeswick PD, Wan Y, Geller DA, Nussler AK, Billiar T.R. Remote tissue injury primes hepatocytes for nitric oxide synthesis. J Surg Res 1994; 57: 205-9.
9. Sair M, Etherington PJ, Curzen NP,Winlove CP, Evans T.W. Tissue oxygenation and perfusion in endotoxemia. Am J Physiol 1996; 271: H1620-5.
10. Jelkmann W. Molecular biology of erythropoietin. Int Med 2004; 43: 649-59.
11. Sasaki R, Masuda S, Nagao M. Erythropoietin: multiple physiological functions and regulation of biosynthesis. Biosci Biotechnol Biochem 2000; 64: 1775-93.
12. Maxwell PH, Osmond MK, Pugh CW, et al. Sites of erythropoietin production. Kidney Int 1997; 51: 393-401.
13. Bondurant M, Koury M. Anemia induces accumulation of erythropoietin mRNA in the kidney and liver. Mol Cell Biol 1986; 6: 2731-3.
14. Semenza GL, Wang G.L. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 1992; 12: 5447-54.
15. Semenza G.L. Signal transduction to hypoxia-inducible factor 1. Biochem Pharm 2002; 64: 993-8.
16. Yoon D, Pastore YD, Divoky V, et al. Hypoxia-inducible factor-1 deficiency results in dysregulated erythropoiesis signalling and iron homeostasis in mouse development. J Biol Chem 2006; 281: 25703-11.
17. Haddad JJ, Land S.C. A non-hypoxic, ROS-sensitive pathway mediates TNF-alpha-dependent regulation of HIF-1a. FEBS Lett 2001; 505: 269-74.
18. Tanaka H, Yamamoto M, Hashimoto N, et al. Hypoxiaindependent overexpression of hypoxia-inducible factor 1a as an early change in mouse hepatocarcinogenesis. Cancer Res 2006; 66: 11263-70.
19. Bilton RL, Booker G.W. The subtle side to hypoxia-inducible factor (HIFa) regulation. Eur J Biochem 2003; 270: 791-8.
20. Shang Y, Li X, Prasad PV, et al. Erythropoietin attenuates lung injury in lipopolysaccharide treated rats. J Surg Res 2009; 155: 104-10.
21. Davis PA, Mormino P, Calo L.A. Erythropoietin, heme oxygenase-1 and vascular tissue protective effects. Clin Nephrol 2009; 71: 365-6.
22. Zhu L, Jin W, Pan H, et al. Erythropoietin inhibits the increase of intestinal labile zinc and the expression of inflammatory mediators after traumatic brain injury in rats. J Trauma 2009; 66: 730-6.
23. Aoshiba K, Onizawa S, Tsuji T, Nagai A. Therapeutic effects of erythropoietin in murine models of endotoxin shock. Crit Care Med 2009; 37: 889-98.
24. Noguchi Y, Goto T, Yufu Y, et al. Gene expression of erythropoietin in renal cell carcinoma. Int Med 1999; 38: 991-4.
25. Villavedra M, Carol H, Hjulstrom M, et al. 'PERFEXT': a direct method for quantitative assessment of cytokine production in vivo at the local level. Res Immunol 1997; 148: 257-66.
26. Tron K, Samoylenko A, Musikowski G, et al. Regulation of rat heme oxygenase-1 expression by IL-6 via the JAK/STAT pathway in hepatocytes. J Hepatol 2006; 45: 72-80.
27. Haralanova-Ilieva B, Ramadori G, Armbrust T. Expression of osteoactivin in rat and human liver and isolated rat liver cells. J Hepatol 2005; 42: 565-72.
28. Ferrucci L, Guralnik JM, Woodman RC, et al. Pro-inflammatory state and circulating erythropoietin in persons with and without anemia. Am J Med 2005; 118: 1288.e11-9.
29. Tacke F, Schöffski P, Luedde T, et al. Analysis of factors contributing to higher erythropoietin levels in patients with chronic liver disease. Scand J Gastroenterol 2004; 39: 259-66.
30. Mori K, Fujimoto-Ouchi K, Onuma E, et al. Novel models of cancer-related anemia in mice inoculated with IL-6-producing tumor cells. Biomed Res 2009; 30: 47-51.
31. Sohmiya M, Kato Y. Human growth hormone and insulinlike growth factor-I inhibit erythropoietin secretion from the kidneys of adult rats. J Endocrinol 2005; 184: 199-207.
32. Faquin WC, Schneider TJ, Goldberg M.A. Effect of inflammatory cytokines on hypoxia-induced erythropoietin production. Blood 1992; 79: 1987-94.
33. Hu CJ, Wang LY, Chodosh LA, Keith B, Simon M.C. Differential roles of hypoxia inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation. Mol Cell Biol 2003; 23: 9361-74.
34. Rankin EB, Biju MP, Liu Q, et al. Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo. J Clin Invest 2007; 117: 1068-77.
35. Mastrogiannaki M, Matak P, Keith B, et al. HIF-2a, but not HIF-1a, promotes iron absorption in mice. J Clin invest 2009; 119: 1159-66.
36. Xu Q, Briggs J, Park S, et al. Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signalling pathways. Oncogene 2005; 24: 5552-60.
37. Niu G, Briggs J, Deng J, et al. Signal transducer and activator of transcription 3 is required for hypoxia-inducible factor-1a RNA expression in both tumor cells and tumor-associated myeloid cells. Mol Cancer Res 2008; 6: 1099-105.
38. Wiesener MS, Jurgensen JS, Rosenberger C, et al. Widespread hypoxia-inducible expression of HIF-2alpha in distinct cell populations of different organs. FASEB J 2003; 17: 271-3.
39. Hellwig-Bürgel T, Rutkowski K, Metzen E, et al. Interleukin-1b and tumor necrosis factor-a stimulate DNA binding of hypoxia-inducible factor-1. Blood 1999; 94: 1561-7.
40. Bilton RL, Booker G.W. The subtle side to hypoxia inducible factor (HIFalpha) regulation. Eur J Biochem 2003; 270: 791-8.
41. Jung YJ, Isaacs JS, Lee S, Trepel J, Neckers L. IL-1beta mediated up-regulation of HIF-1alpha via NFkappaB/ COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis. FASEB J 2003; 17: 2115-7.
42. Bracken CP, Whitelaw ML, Peet D.J. Activity of hypoxiainducible factor 2a is regulated by association with the NFkB essential modulator. J Biol Chem 2005; 280: 14240-51.
43. Ghezzi P, Brines M. Erythropoietin as an antiapoptotic, tissue-protective cytokine. Cell Death Differ 2004; 11: S37-44.